On the latest edition of CNBC's Halftime Report Final Trades, the program highlighted several major stock movements and analyst perspectives. ServiceNow shares closed the session up 6.9%, settling at $105.56. Meanwhile, Meta Platforms saw its stock decline 0.2% to finish the day at $593.87.
The segment also featured a discussion on Incyte Corp. (NASDAQ: INCY). According to the provided data, Incyte's stock price was last updated at $123.23 on September 16, 2026. The company operates within the Health Care sector and the Biotechnology industry. Incyte focuses on the discovery and development of small-molecule drugs. Its leading marketed drug, Jakafi, treats two types of rare blood cancer and graft versus host disease, and is partnered with Novartis.
Financial metrics for Incyte include a market capitalization of $24.98 billion and a price-to-earnings ratio of 15.51. The company reported an earnings per share (EPS) of $2.92, which the data notes is better than the industry average. Incyte does not currently pay a dividend.
